Summary: The AREDS2 dietary supplement that substitutes antioxidants lutein and zeaxanthin for beta-carotene reduces the risk of age-related macular degeneration progression, a new study reveals. Source: NIH The Age-Related Eye Disease Studies (AREDS and AREDS2) established that dietary supplements can slow progression of age-related macular degeneration (AMD), the most common cause of […]
degeneration
NIH study confirms benefit of supplements for slowing age-related macular degeneration
News Release Thursday, June 2, 2022 After 10 years, AREDS2 formula shows increased efficacy compared to original formula, benefit of eliminating beta-carotene. The Age-Related Eye Disease Studies (AREDS and AREDS2) established that dietary supplements can slow progression of age-related macular degeneration (AMD), the most common cause of blindness in […]